Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT AND CEO

Sr. VP and CFO

Sr. VP, Operations

President and CEO

VP, Research & Development

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. It also develops PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; FundaÃƒÂ§ÃƒÂ£o Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is based in Hackensack, New Jersey. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-01	Premium	acquired	Premium	Premium	Premium	PRESIDENT AND CEO
2023-10-19	Premium	bought	Premium	Premium	Premium	PRESIDENT AND CEO
2023-08-15	Premium	acquired	Premium	Premium	Premium	Sr. VP and CFO
2023-08-15	Premium	acquired	Premium	Premium	Premium	Sr. VP, Operations
2023-08-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-08-15	Premium	acquired	Premium	Premium	Premium	VP, Research & Development
2023-01-03	Premium	bought	Premium	Premium	Premium	-
2022-04-11	Premium	bought	Premium	Premium	Premium	President and CEO
2022-02-25	Premium	acquired	Premium	Premium	Premium	Sr. VP and CFO
2022-02-25	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-06-03	Premium	sold	Premium	Premium	Premium	-
2021-06-02	Premium	sold	Premium	Premium	Premium	-
2020-08-11	Premium	acquired	Premium	Premium	Premium	Sr. VP and CFO
2020-08-11	Premium	acquired	Premium	Premium	Premium	President and CEO
2020-04-07	Premium	bought	Premium	Premium	Premium	-

PLX - Protalix BioTherapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PLX